Skip to content

Low-Dose Esketamine Administration and its Effect on Preventing Emergence Agitation in Patients after Nasal Endoscopic Surgery with Nasal Packing under General Anesthesia

Low-Dose Esketamine Administration and its Effect on Preventing Emergence Agitation in Patients after Nasal Endoscopic Surgery with Nasal Packing under General Anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112380
Enrollment
Unknown
Registered
2025-11-13
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence agitation,EA

Interventions

Control group:No premedication + Intravenous injection of normal saline half an hour before the end of surgery.
Esketamine group:No premedication+Administer Esketamine Injection Half an Hour Before Surgery Conclusion
Preconditioning group:Preoperative Nasal Tamponade with Sponge and Mouth-Breathing Training + Intravenous Normal Saline Injection Half an Hour Before Surgery Conclusion
Preconditioning+Esketamine group:Preoperative Nasal Tamponade with Sponge and Mouth-Breathing Training + Administer Esketamine Injection Half an Hour Before Surgery Conclusion

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.?Elective endoscopic sinus surgery under general anesthesia; 2.Aged 18 and above; 3.ASA classification I - II; 4.No respiratory or circulatory system disorders; 5.Preoperative Anxiety Scale (PAS-7) score < 8; 6.Normal liver and kidney function;

Exclusion criteria

Exclusion criteria: 1.patients undergoing secondary or multiple nasal surgeries; 2.Contraindicated in individuals with known hypersensitivity to the investigational drug or other anesthetic agents; 3.Patients diagnosed with psychiatric disorders, neurological diseases, and those on long-term psychotropic medication; 4.Preoperative Anxiety Scale (PAS-7) score >= 8; 5.Participation in other clinical trials within one month before the start of this study; 6.Enrollment in any other clinical trial within the month preceding the initiation of this study;

Design outcomes

Primary

MeasureTime frame
Sedation-agitation Scale ,SAS;

Secondary

MeasureTime frame
Perioperative anxiety scale,PAS-7;Wong-Baker FACES Pain Rating Scale;Time of patient extubation;Occurrence of postoperative adverse reactions;

Countries

China

Contacts

Public ContactSong Fuhu

The Third Affiliated Hospital of Southern Medical University

songfuhu@126.com+86 20 6278 4240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026